![A MicroRNA-1–Mediated Inhibition of the NF-κB Pathway by the JAK-STAT Pathway in the Invertebrate Litopenaeus vannamei | The Journal of Immunology A MicroRNA-1–Mediated Inhibition of the NF-κB Pathway by the JAK-STAT Pathway in the Invertebrate Litopenaeus vannamei | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/204/11/2918/F1.large.jpg)
A MicroRNA-1–Mediated Inhibition of the NF-κB Pathway by the JAK-STAT Pathway in the Invertebrate Litopenaeus vannamei | The Journal of Immunology
![JAK–STAT pathway targeting for the treatment of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology JAK–STAT pathway targeting for the treatment of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-020-0273-0/MediaObjects/41575_2020_273_Fig1_HTML.png)
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
![Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2050-7771-1-5/MediaObjects/40364_2012_Article_5_Fig1_HTML.jpg)
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
![Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma | Future Medicinal Chemistry Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.16.4/asset/images/medium/figure2.gif)
Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma | Future Medicinal Chemistry
![Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma - Journal of Hepatology Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a525461f-4e9e-416e-9f2f-2f8fa7888b81/ga1_lrg.jpg)
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma - Journal of Hepatology
![Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/97e63972-818e-4de6-b892-901e9a9a7cd0/b1_lrg.jpg)